People Beijing, June 14 (Reporter Ma Xiaohui) "Baby 6 months old, sick and cough runny nose, the doctor opened the anti-inflammatory drugs, but the drug requires eating half a bag each time. Are not you allowed? What are the problems that mothers solve? "Often, a group of journalists joining a parenting group raised similar questions. With the recent issuance of "Several Opinions on Safeguarding Children's Drugs" jointly issued by six departments including the National Health and Family Planning Commission, this situation is expected to be improved.

Lack of children's medicine parents worried about drug companies helpless

At present, the shortage of children's medicines in the market makes adult medicine "break apart to eat" and "cut open to eat", which has become a helpless choice for pediatricians. The amount of drugs in the manual column "children reduce, halve" and so on is to confused parents, many parents can only choose "blind with Meng eat."

This reporter has learned that the lack of clinical experience of children's medicines, pharmaceutical factories producing children's low profit margins, difficulties and so are all children drug-specific reasons. Children's low-profit drugs, research and development, production, marketing and many other aspects of the lack of policy support, to a large extent affected the production of pharmaceutical companies enthusiasm.

"There are only a few 60 kinds of children's medicines in our country, indeed fewer." Ren Wu-yian, chairman of Ya Bao Pharmaceutical said in an interview with People's Daily that the lack of children's medicines has brought great difficulties to doctors and children's parents. At present, adults can only be divided into several drugs for children to eat. However, this method of taking medicine, one may eat less, less effective, the second, eat more may adverse reactions.

"Why children's drug development lag? One is the profit margins." Renwu Xian believes that more importantly, the children are parents treasure, the development of new drugs are reluctant to allow their children to do clinical trials, and new drugs before the market must be done Test, which is a difficult and bottleneck for pharmaceutical companies. Now study children's medicine must ensure that side effects are small, adults must use a number of years, based on a large number of validation through to the development of children's medicine.

"Children's Phase II Phase III clinical research is extremely difficult." Sims Pharmaceutical Group, director of marketing Wen Qian also agreed Renwu Xian's view, "ethically, it is difficult for parents to accept the need to do clinical trials through children's requirements." "

Multi-sectoral collaboration to facilitate the development of children's medicine

In this regard, the National Health and Family Planning Commission and other six departments jointly held a media briefing will be that the current children appropriate drug varieties, dosage forms and specifications of enterprises lack of research and development momentum and enthusiasm for production, irrational drug use problems still exist, children drug safety challenges. In order to alleviate the difficulties of children's medication and ventilation, a number of opinions on the protection of children's medication (hereinafter referred to as "opinions") were read.

National Health and Family Planning Commission, the relevant departments responsible for doing a good job of children's medication when asked that the introduction of the document, will promote more businesses take the initiative for the majority of children "tailored" the appropriate dosage form and specifications of medicines, the doctor assured, parents feel at ease Children easy to use, easy to use children's drug research and development production will be encouraged by the policy and support.

"Good medicine is not bitter, quantitative does not rely on hand," plagued doctors and children "no medicine can be opened," "no medicine available" will gradually ease the problem for the scientific and rational use of children to create good convenience and conditions.

Relevant manufacturing enterprises ushered in good news

"I hope that all levels of departments should give preferential treatment to the development of children's medicines, give green channels for research and approval, and support research and development costs so as to promote more children's medicines so that the next generation will grow healthier." Ren Wu Xian In an interview with reporters expressed as a business side of the wish.

The head of the relevant departments of the State Health and Family Planning Commission pointed out that the introduction of this Opinion will be conducive to mobilizing the enthusiasm of children's drug production and circulation enterprises and further improving and alleviating the current situation of under-medication in children.

Enterprises should urgently approve the examination and approval progress when they declare the appropriate varieties, dosage forms and specifications for the children who are in urgent need of clinical treatment. Enterprises may also make reference to the catalog of children's medicines that are encouraged to be developed, clarify the direction of research and development, focus on major breakthroughs and obtain policy support. In addition, enterprises may With reference to industry consensus and children's medication guidelines, supplement and perfect children's medication data, revise drug manuals in a timely manner and promote R & D and production.

"This is really a good news for children's medicine makers!" Wen Qian said that before the "Opinion", Shenwei has been in product packaging has been upgraded. To help parents get more accurate dose while giving their children medicine, the company changed its packaging design into a strip of coffee-like flour. "Opinions" issued a more firm business development, children's confidence in manufacturing medicine.

The Opinion emphasizes that it is necessary to give full play to the traditional advantages of traditional Chinese medicine and the appropriate dosage form for children. The specifications will be promptly included into the payment of basic medical insurance as required, and encourage enterprises to organize production actively. Premium companies also expressed their willingness to accept higher quality and safety control standards.

"This kind of move will make the real fun for companies that really provide children with safe and effective drugs." Wen Qian said that with the "opinion" landing, the future of the children's drug market will develop more and more rapidly, seize the opportunity, The adjustment and planning of the product line has become an urgent task to be done by enterprises.